alborixin has been researched along with Colonic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ali, SA; Hamid, A; Hussain, A; Kumar, A; Makhdoomi, US; Mushtaq, S; Qazi, AK; Qazi, PH; Rehman, SU; Shah, A; Shah, AM; Wani, A | 1 |
1 other study(ies) available for alborixin and Colonic Neoplasms
Article | Year |
---|---|
Isolation and characterization of alborixin from Streptomyces scabrisporus: A potent cytotoxic agent against human colon (HCT-116) cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Colon; Colonic Neoplasms; HCT116 Cells; Humans; Membrane Potential, Mitochondrial; Pyrans; Reactive Oxygen Species; Streptomyces | 2016 |